NDT Pharmaceuticals Inc.
NDTP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | – | – |
| Short-Term Investments | $0 | $0 | – | – |
| Receivables | $0 | $0 | – | – |
| Inventory | $0 | $0 | – | – |
| Other Curr. Assets | $2 | $8 | – | – |
| Total Curr. Assets | $2 | $8 | – | – |
| Property Plant & Equip (Net) | $0 | $0 | – | – |
| Goodwill | $0 | $0 | – | – |
| Intangibles | $0 | $0 | – | – |
| Long-Term Investments | $142 | $142 | – | – |
| Tax Assets | $0 | $0 | – | – |
| Other NC Assets | $0 | $0 | – | – |
| Total NC Assets | $142 | $142 | – | – |
| Other Assets | $0 | $0 | – | – |
| Total Assets | $144 | $150 | – | – |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | – | – |
| Short-Term Debt | $0 | $0 | – | – |
| Tax Payable | $0 | $0 | – | – |
| Deferred Revenue | $0 | $0 | – | – |
| Other Curr. Liab. | $77 | $72 | – | – |
| Total Curr. Liab. | $77 | $72 | – | – |
| LT Debt | $0 | $0 | – | – |
| Deferred Rev, NC | $0 | $0 | – | – |
| Deferred Tax Liab, NC | $0 | $0 | – | – |
| Other NC Liab. | $0 | $0 | – | – |
| Total NC Liab. | $0 | $0 | – | – |
| Other Liabilities | $0 | $0 | – | – |
| Cap. Leases | $0 | $0 | – | – |
| Total Liabilities | $77 | $72 | – | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | – | – |
| Common Stock | $16 | $16 | – | – |
| Retained Earnings | -$139 | -$130 | – | – |
| AOCI | $0 | $0 | – | – |
| Other Equity | $192 | $192 | – | – |
| Total Equity | $69 | $78 | – | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | – | – |
| Total Liab. & Tot. Equity | $146 | $150 | – | – |
| Net Debt | -$1 | -$1 | $0 | $0 |